About Eric Aguiar
Form D filings for Garuda Therapeutics from 2021 to 2024 list Eric Aguiar as director.
Eric Aguiar first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Eric Aguiar in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eric Aguiar works with at each company, as listed on that company's latest Form D.
Garuda Therapeutics, Inc. · Form D, Oct 31, 2024
GM
Geoff Meyerson
Director
RK
Raymond Kelleher
Director
SL
Steve Liapis
Director
RS
Rahul Singhvi
Director
DK
David Kirske
Executive officer
CG
Carl Gordon
Director
AC
Adam Craig
President and CEO, director